BRCA1抑制假说：对BRCA1患者组织特异性肿瘤发展的一种解释。 - Suppr

Suppr

超能文献

The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.

作者信息

Elledge Stephen J, Amon Angelika

出版信息

Cancer Cell. 2002 Mar;1(2):129-32. doi: 10.1016/s1535-6108(02)00041-7.

DOI:10.1016/s1535-6108(02)00041-7

PMID:12086871

Abstract

摘要

相似文献

The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.

Cancer Cell. 2002 Mar;1(2):129-32. doi: 10.1016/s1535-6108(02)00041-7.

No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.

Breast Cancer Res Treat. 2008 Jan;107(1):155-6. doi: 10.1007/s10549-007-9521-z. Epub 2007 Feb 15.

Mechanisms of BRCA1 tumor suppression.

Cancer Discov. 2012 Aug;2(8):679-84. doi: 10.1158/2159-8290.CD-12-0221. Epub 2012 Jul 27.

A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.

Int J Bioinform Res Appl. 2011;7(1):1-14. doi: 10.1504/IJBRA.2011.039166.

BRCA1: what do we know? What do we think we know? What do we really need to know?

Gynecol Oncol. 2000 Mar;76(3):291-3. doi: 10.1006/gyno.2000.5742.

Possible function found for breast cancer genes.

Science. 1997 Apr 25;276(5312):531-2. doi: 10.1126/science.276.5312.531.

BRCA1 in breast and ovarian cancer predisposition.

Cancer Lett. 2005 Sep 8;227(1):1-7. doi: 10.1016/j.canlet.2004.11.006. Epub 2004 Dec 13.

Biology of hereditary breast and ovarian cancers.

Ann Oncol. 2013 Nov;24 Suppl 8:viii7. doi: 10.1093/annonc/mdt309.

Deciphering the BRCA1 Tumor Suppressor Network.

J Biol Chem. 2015 Jul 17;290(29):17724-17732. doi: 10.1074/jbc.R115.667931. Epub 2015 Jun 5.

DNA repair: Decision at the break point.

Nature. 2010 May 20;465(7296):301-2. doi: 10.1038/465301a.

引用本文的文献

Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

Cancer Discov. 2025 Mar 3;15(3):461-480. doi: 10.1158/2159-8290.CD-24-1326.

BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.

Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124.

A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.

Genetics. 2024 Oct 15;228(4). doi: 10.1093/genetics/iyae166.

Oncogenic BRCA1,2 Mutations in the Human Lineage-A By-Product of Sexual Selection?

Biomedicines. 2023 Dec 21;12(1):22. doi: 10.3390/biomedicines12010022.

Tissue-adjusted pathway analysis of cancer (TPAC): A novel approach for quantifying tumor-specific gene set dysregulation relative to normal tissue.

PLoS Comput Biol. 2024 Jan 11;20(1):e1011717. doi: 10.1371/journal.pcbi.1011717. eCollection 2024 Jan.

A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.

medRxiv. 2024 Oct 4:2023.12.08.23299304. doi: 10.1101/2023.12.08.23299304.

A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos.

Sci Transl Med. 2022 Oct 5;14(665):eabo1050. doi: 10.1126/scitranslmed.abo1050.

The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP.

Front Cell Dev Biol. 2022 Apr 20;10:889656. doi: 10.3389/fcell.2022.889656. eCollection 2022.

G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency.

Genes (Basel). 2022 Feb 22;13(3):391. doi: 10.3390/genes13030391.

Analyzing cancer gene expression data through the lens of normal tissue-specificity.

PLoS Comput Biol. 2021 Jun 18;17(6):e1009085. doi: 10.1371/journal.pcbi.1009085. eCollection 2021 Jun.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.

Cancer Cell. 2002 Mar;1(2):129-32. doi: 10.1016/s1535-6108(02)00041-7.

No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.

Breast Cancer Res Treat. 2008 Jan;107(1):155-6. doi: 10.1007/s10549-007-9521-z. Epub 2007 Feb 15.

Mechanisms of BRCA1 tumor suppression.

Cancer Discov. 2012 Aug;2(8):679-84. doi: 10.1158/2159-8290.CD-12-0221. Epub 2012 Jul 27.

A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.

Int J Bioinform Res Appl. 2011;7(1):1-14. doi: 10.1504/IJBRA.2011.039166.

BRCA1: what do we know? What do we think we know? What do we really need to know?

Gynecol Oncol. 2000 Mar;76(3):291-3. doi: 10.1006/gyno.2000.5742.

Possible function found for breast cancer genes.

Science. 1997 Apr 25;276(5312):531-2. doi: 10.1126/science.276.5312.531.

BRCA1 in breast and ovarian cancer predisposition.

Cancer Lett. 2005 Sep 8;227(1):1-7. doi: 10.1016/j.canlet.2004.11.006. Epub 2004 Dec 13.

Biology of hereditary breast and ovarian cancers.

Ann Oncol. 2013 Nov;24 Suppl 8:viii7. doi: 10.1093/annonc/mdt309.

Deciphering the BRCA1 Tumor Suppressor Network.

J Biol Chem. 2015 Jul 17;290(29):17724-17732. doi: 10.1074/jbc.R115.667931. Epub 2015 Jun 5.

DNA repair: Decision at the break point.

Nature. 2010 May 20;465(7296):301-2. doi: 10.1038/465301a.

引用本文的文献

Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

Cancer Discov. 2025 Mar 3;15(3):461-480. doi: 10.1158/2159-8290.CD-24-1326.

BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.

Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124.

A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.

Genetics. 2024 Oct 15;228(4). doi: 10.1093/genetics/iyae166.

Oncogenic BRCA1,2 Mutations in the Human Lineage-A By-Product of Sexual Selection?

Biomedicines. 2023 Dec 21;12(1):22. doi: 10.3390/biomedicines12010022.

Tissue-adjusted pathway analysis of cancer (TPAC): A novel approach for quantifying tumor-specific gene set dysregulation relative to normal tissue.

PLoS Comput Biol. 2024 Jan 11;20(1):e1011717. doi: 10.1371/journal.pcbi.1011717. eCollection 2024 Jan.

A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.

medRxiv. 2024 Oct 4:2023.12.08.23299304. doi: 10.1101/2023.12.08.23299304.

A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos.

Sci Transl Med. 2022 Oct 5;14(665):eabo1050. doi: 10.1126/scitranslmed.abo1050.

The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP.

Front Cell Dev Biol. 2022 Apr 20;10:889656. doi: 10.3389/fcell.2022.889656. eCollection 2022.

G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency.

Genes (Basel). 2022 Feb 22;13(3):391. doi: 10.3390/genes13030391.

Analyzing cancer gene expression data through the lens of normal tissue-specificity.

PLoS Comput Biol. 2021 Jun 18;17(6):e1009085. doi: 10.1371/journal.pcbi.1009085. eCollection 2021 Jun.